Study Product Accountability Sample Clauses

Study Product Accountability. ‌ Upon receipt of the study products, the Investigator or designee will conduct an inventory. In accordance with federal regulations, the Investigator must agree to keep all test article in a secure location with restricted access. Designated study personnel will provide the test article to the subjects in accordance with the protocol. During the study, the Investigator must maintain records of study treatment dispensation and collection for each subject. This record must be made available to the study monitor for the purposes of verifying the accounting of clinical supplies. Any discrepancies and/or deficiencies between the observed disposition and the written account must be recorded along with an explanation. At the conclusion of the study, the Investigator will be responsible for returning all unused study product (i.e., Sculptra®) unless otherwise instructed by the Sponsor. Shipping label and cost will be provided to the Investigator by the Sponsor.
Sample 1
AutoNDA by SimpleDocs
Study Product Accountability. The A5208/OCTANE site pharmacist is required to maintain complete records of all study products received from the NIAID Clinical Research Products Management Center and subsequently dispensed. Further instruction will be provided by the DAIDS Pharmaceutical Affairs Branch regarding final disposition of unused study products. The procedures to be followed are provided in the manual, Pharmacy Guidelines and Instructions for DAIDS Clinical Trials Networks, in the section Study Product Management Responsibilities.
Sample 1

Related to Study Product Accountability

  • Accountability 5.3.1 Actuaries and external auditors will be appointed by the Trust. Audited financial statements, and an actuarial evaluation report will be obtained for the Trust on an annual basis. The actuarial report will include projections regarding the adequacy of contributions to cover projected benefit and related costs for the Trust for a period of not less than 3 years into the future.

  • A Service Accountability Agreement This Agreement is a service accountability agreement for the purposes of section 20(1) of LHSIA.

  • Service Accountability Agreements The HSP acknowledges that if the LHIN and the HSP enter into negotiations for a subsequent service accountability agreement, subsequent funding may be interrupted if the next service accountability agreement is not executed on or before the expiration date of this Agreement.

  • LIABILITY AND ACCOUNTABILITY The Provider, if a non-profit entity, will provide continuous and adequate director, officer, and employee liability insurance coverage against any personal liability or accountability by reason of actions taken while acting within the scope of their authority during the existence of this Agreement and any renewal and extension thereof. Such coverage may be provided by a self-insurance program established and operating under the laws of the state of Florida.

  • Health Care Accountability Ordinance If Administrative Code Chapter 12Q applies to this contract, Contractor shall comply with the requirements of Chapter 12Q. For each Covered Employee, Contractor shall provide the appropriate health benefit set forth in Section 12Q.3 of the HCAO. If Contractor chooses to offer the health plan option, such health plan shall meet the minimum standards set forth by the San Francisco Health Commission. Information about and the text of the Chapter 12Q, as well as the Health Commission’s minimum standards, is available on the web at xxxx://xxxxx.xxx/olse/hcao. Contractor is subject to the enforcement and penalty provisions in Chapter 12Q. Any Subcontract entered into by Contractor shall require any Subcontractor with 20 or more employees to comply with the requirements of the HCAO and shall contain contractual obligations substantially the same as those set forth in this Section.

Time is Money Join Law Insider Premium to draft better contracts faster.